Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US7033831

Title:Islet cells from human embryonic stem cells
Inventors:Fisk, Gregory J.; Fremont, CA, USA
Inokuma, Margaret S.; San Jose, CA, USA
Summary:This invention describes a novel system for producing pancreatic islet cells derived from embryonic stem cells. Methods are disclosed by which differentiation is initiated towards endoderm cells, and focused using reagents that promote the emergence of islet precursors and mature insulin-secreting cells. Also described are methods by which high quality populations of islet cells can be produced in commercial quantities for use in research, drug screening, or regenerative medicine, especially in the treatment of conditions associated with a deficiency of insulin, glucagon or somatostatin such as type I diabetes.
Abstract:This disclosure provides a system for producing pancreatic islet cells from embryonic stem cells. Differentiation is initiated towards endoderm cells, and focused using reagents that promote emergence of islet precursors and mature insulin-secreting cells. High quality populations of islet cells can be produced in commercial quantities for use in research, drug screening, or regenerative medicine.
US Patent Website:Click Here for Full Text of Patent
Title Number:US7033831
Application Number:US2002000313739
Date Filed:06/12/2002
Date Published:25/04/2006
Assignee:Geron Corporation, Menlo Park, CA, USA


 
Copyright © 2007 The Institute for Cellular Medicine  6/13/2021